Mycoplasma-Free CGT with NGS-Based Biosafety Testing
Watch our demo video and discover how to perform NGS-based biosafety testing to detect contaminants such as Mycoplasma to ensure the biosafety of your cell line and biotherapeutics. NGS technology provides an untargeted, accurate and rapid method for identiying all biological contamination of the sample and is suitable for testing starting materials, unprocessed bulk harvest, and the final product. Find out how to do this step-by-step with our enterprise software solution Genedata Selector®.
What you can see in our demo video:
- Screening the samples against the reference database
- The breadth of coverage and the type of detected mycoplasma
- Results visualized in the software and in the generated PDF report